Trump’s $1.4 trillion tariff threat spurs companies to seek coverCompanies like Novo Nordisk, Boeing, and Walmart are preparing for the impacts of President Donald Trump’s tariffs. Executives are assessin...
13 Mar, 2025, 10.04 AM IST
Swiss chemical company Clariant AG forms JV with India GlycolsAs per the terms of the agreement, India Glycols will contribute its renewable Bio-EO derivative business to the JV, which includes a multi...
12 Mar, 2021, 12.12 AM IST
Novartis scraps sale of assets including COVID-19 hopeful to India's AurobindoNovartis AG on Thursday scrapped the $1 billion sale of U.S. generic pill and skin drug assets to India's Aurobindo Pharma Ltd as regulator...
02 Apr, 2020, 12.37 PM IST
Buy Aurobindo Pharma, target Rs 836: Elara CapitalBuy Aurobindo Pharma Ltd. at a price target of Rs 836.
11 Sep, 2018, 08.19 AM IST
KPMG appoints Ajaz Hussain as senior advisorAjaz Hussain is currently serving as the President of The National Institute for Pharmaceutical Technology and Education, a not-for-profit ...
08 Mar, 2017, 01.26 PM IST
Sun Pharma gets boost with US FDA approval for GleevecSun Pharmaceutical announced it received approval from the US FDA for generic copies of Gleevec, a drug that treats chronic myeloid leukemi...
04 Dec, 2015, 11.43 AM IST
Novartis gets USFDA warning letter for two plants in IndiaSandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...
28 Oct, 2015, 07.04 PM IST
US court finds Teva's Copaxone patent invalid again: Natco PharmaNatco Pharma, a city-based drug maker, today said the US Court of Appeals for Federal Court has again found one of the patents of Teva's Co...
19 Jun, 2015, 04.00 PM IST
Natco slumps; US court rules for Teva in drug patent caseUS Supreme Court sends patent case back to lower court. Generic launches by Natco and other pharma companies will be delayed, say analysts.
21 Jan, 2015, 07.42 PM IST
Natco Pharma cracks 19% as US justices agrees to hear Teva's Copaxone appealThe decision by the Supreme Court comes at a time when Teva is switching its daily version of Copaxone to twice a week version.
01 Apr, 2014, 10.27 AM IST
Drugs pricing row: 7 pharmaceutical companies move HC against Centre's orderSeven more pharmaceutical companies including Novartis India Limited today moved the Delhi High Court to challenge the government's new dru...
05 Aug, 2013, 06.45 PM IST
- Novartis says Q1 profit up 49 pc
Drug maker Novartis AG said on Tuesday that strong sales particularly of swine flu vaccine helped increase net profit by 49 per cent to $2....
20 Apr, 2010, 12.52 PM IST
- Novartis buys part of generics maker for $1.2 bn
Swiss pharmaceuticals giant Novartis AG will buy the generic injectable cancer drugs business of Austria's EBEWE Pharma for euro925 million...
21 May, 2009, 04.15 AM IST
- Retailers end boycott of Novartis
Over 7,000 retailers and stockists had stopped selling all the 198 medicines of two firms from April 1, protesting the drugmakers’ practice...
13 Apr, 2009, 02.06 AM IST
- Novartis posts 7% rise in Q1 net profit
Pharmaceuticals maker Novartis AG reported a 7 percent rise in first-quarter net income on Monday on the back of a declining dollar and sol...
21 Apr, 2008, 11.19 PM IST
- Drugmakers may get EU tariff relief
The European Union may trim import tariffs on Indian drugmakers including Ranbaxy Laboratories because of evidence that subsidies fell, a s...
11 Sep, 2007, 09.33 PM IST
- Cipla, PEs team up for Merck's biz
Ranbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
16 Mar, 2007, 02.08 AM IST